Table 1.
Characteristics of study participants comparing remitters from non-remitters.
| Remitters (n = 255) | Non-remitters (n = 272) | p-value | |
|---|---|---|---|
| Mean (SD) | |||
| Age* | 50.6 (13.8) | 53.4 (13.5) | 0.424 |
| Baseline BMI* | 28.1 (5.6) | 28.3 (5.8) | 0.742 |
| Baseline MADRS score* | 29.7 (4.7) | 33.0 (4.7) | 6.36E-13 |
| N (%) | |||
| Gender, female | 153 (60.0) | 175 (64.3) | 0.349 |
| Study | 7.34E−05 | ||
| TRANSFORM-3 | 10 (3.9) | 39 (14.3) | |
| SUSTAIN-2 | 245 (96.1) | 233 (85.7) | |
| Concomitant antidepressant medications | 0.782 | ||
| DULOXETINE | 90 (35.3) | 87 (32.0) | |
| ESCITALOPRAM | 78 (30.6) | 80 (29.4) | |
| SERTRALINE | 42 (16.5) | 52 (19.1) | |
| VENLAFAXINE XR | 45 (17.6) | 52 (19.1) | |
| None | 1 (0.4) | ||
*p-value reported is based on type III test statistics controlling for study.